Naltrexone Treatment Centers in Louisiana

Patients 16 and older can generally be admitted to MAT including naltrexone with parental consent; some Louisiana providers specialize in youth MAT and follow American Academy of Pediatrics guidance. For patients under 18, two documented failed detox attempts are typically required before methadone, per federal rule.

Yes. Louisiana receives federal State Opioid Response (SOR) funding that subsidizes MAT for uninsured patients at participating agencies. The national SAMHSA helpline (1-800-662-4357) can refer you to SOR-funded naltrexone providers in your area.

You can apply to Healthy Louisiana online at the Louisiana state website, in person at a county office, or through naltrexone providers that offer enrollment assistance. Most applications are decided within 45 days; emergency Medicaid may be available sooner for urgent care.

Most Louisiana commercial plans do not require a PCP referral for behavioral-health or MAT services; you can typically self-refer to a naltrexone provider. HMO plans may require a referral — check your plan’s Summary of Benefits.

No. A 2022 Department of Justice enforcement action confirmed that Louisiana drug courts cannot ban FDA-approved MAT medications; doing so violates the ADA. Patients in drug court have the legal right to remain on their prescribed naltrexone regimen.

For some patients, naltrexone is lifelong — the same way insulin or blood-pressure medication is. For others, treatment ends after sustained recovery. The decision to taper is always clinical, made together by patient and provider based on stability, not on arbitrary time limits.

Louisiana’s opioid-response infrastructure funds bridge clinics, emergency-department induction, and telehealth buprenorphine specifically to fill same-day gaps. If the closest clinic has a waitlist, your intake counselor will refer you to the next nearest opening.

Yes. Basic labs include a urine drug screen, pregnancy test (if applicable), hepatitis and HIV testing (offered, not mandatory), liver-function tests, and for methadone an ECG to screen QTc interval. Labs are usually drawn at intake; results guide medication selection.

For sublingual buprenorphine or oral methadone, take the next dose at the scheduled time — do not double up. For monthly Sublocade or Vivitrol, contact your Louisiana clinic immediately if you miss the injection window to schedule a catch-up visit and prevent withdrawal or overdose relapse risk.

Standard labor epidurals are fully compatible with MAT. If post-operative opioid pain relief is needed after cesarean, higher doses may be required due to tolerance. The Louisiana anesthesiology and MAT teams coordinate the post-operative pain plan before delivery.

Typical frequency is weekly individual counseling plus a weekly group during the first 3 months, then biweekly or monthly as stability increases. Louisiana programs adjust frequency based on clinical need, insurance coverage, and patient preference.

Yes, with proper documentation. Bring a letter from your Louisiana MAT prescriber, medication in its original pharmacy container, and check destination-country rules — some countries restrict methadone and buprenorphine. The International Narcotics Control Board maintains destination-country guidance.